Thus, the binding of plinabulin and subsequent activation of the GEF-H1 signaling pathway enhances the presentation of tumor antigens to CD8 T-cells, resulting in antitumor immunity [75]. This evidence concerns the gene ARHGEF2 and neoplasm.